ANRO 10-Q: SEC filing
Alto Neuroscience
Filed with the SEC on · accession 0001999480-26-000031
ANRO filed a 10-Q (quarterly report) with the SEC on Nov 10, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved +2.9% by the first close after the filing.
Summary of the filing
Alto Neuroscience filed its Q3 2026 Form 10-Q, reporting quarterly financial results and disclosing ongoing financing activities including private placements, a registered direct offering, and amendments to its loan and security agreement with K2 HealthVentures.
Key details
How ANRO stock reacted
Close before
$27.80
Nov 9, 2026
First close after
+2.91%
$28.61
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for ANRO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ANRO?
Click hereFrequently asked questions
What did ANRO file with the SEC on Nov 10, 2026?
ANRO filed a 10-Q (SEC filing). Alto Neuroscience filed its Q3 2026 Form 10-Q, reporting quarterly financial results and disclosing ongoing financing activities including private placements, a registered direct offering, and amendments to its loan and security agreement with K2 HealthVentures.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did ANRO stock react to this filing?
ANRO closed at $27.80 before the filing and $28.61 on Nov 10, 2026 (+2.91%).
Other ANRO SEC filings
- 8-K · SEC filingNov 10, 2026
- SCHEDULE 13G · SEC filingOct 30, 2026
- 8-K · Executive departureAug 27, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 10-Q · SEC filingAug 12, 2026
- 8-K · SEC filingAug 12, 2026
- 424B5 · Secondary offeringJul 14, 2026
- 8-K · SEC filingJul 14, 2026
Get alerts when ANRO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days